The Europe Thyroid Function Testing Market would witness market growth of 6.0% CAGR during the forecast period (2023-2031).
The Germany market dominated the Europe Thyroid Function Testing Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $445.4 million by 2031. The UK market is exhibiting a CAGR of 5% during (2024 - 2031). Additionally, The France market would experience a CAGR of 6.8% during (2024 - 2031).
Thyroid function testing is essential for diagnosing thyroid disorders by assessing thyroid hormone levels, such as thyroid-stimulating hormone (TSH), thyroxine (T4), and triiodothyronine (T3), as well as detecting specific autoantibodies associated with autoimmune thyroid diseases (anti-thyroid peroxidase antibodies, anti-thyroglobulin antibodies). Accurate diagnosis guides treatment decisions and improves patient outcomes.
Regular monitoring helps adjust treatment regimens and optimize patient management strategies. This is essential in special populations, including pregnant women, neonates, children, and older adults, where thyroid function fluctuations and hormonal changes may impact clinical outcomes. Tailored testing protocols and reference ranges are used to evaluate thyroid function in these populations, ensuring optimal care.
Higher healthcare expenditure in Europe can improve infrastructure and resources for healthcare facilities, including diagnostic laboratories. This can increase accessibility to these services across Europe, particularly in remote or underserved regions where access may have been limited previously. According to Eurostat, Italy currently has a healthcare expenditure of $160 billion, while Spain has $120 billion. Therefore, high expenditure in the healthcare sector is driving the market’s growth.
Based on End-use, the market is segmented into Hospitals, Diagnostic Laboratories, Clinics, and Research Laboratories & Institutes. Based on Test Type, the market is segmented into TSH Test, Free T4 Test, T4 Test, T3 Test, Free T3 Test, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Germany market dominated the Europe Thyroid Function Testing Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $445.4 million by 2031. The UK market is exhibiting a CAGR of 5% during (2024 - 2031). Additionally, The France market would experience a CAGR of 6.8% during (2024 - 2031).
Thyroid function testing is essential for diagnosing thyroid disorders by assessing thyroid hormone levels, such as thyroid-stimulating hormone (TSH), thyroxine (T4), and triiodothyronine (T3), as well as detecting specific autoantibodies associated with autoimmune thyroid diseases (anti-thyroid peroxidase antibodies, anti-thyroglobulin antibodies). Accurate diagnosis guides treatment decisions and improves patient outcomes.
Regular monitoring helps adjust treatment regimens and optimize patient management strategies. This is essential in special populations, including pregnant women, neonates, children, and older adults, where thyroid function fluctuations and hormonal changes may impact clinical outcomes. Tailored testing protocols and reference ranges are used to evaluate thyroid function in these populations, ensuring optimal care.
Higher healthcare expenditure in Europe can improve infrastructure and resources for healthcare facilities, including diagnostic laboratories. This can increase accessibility to these services across Europe, particularly in remote or underserved regions where access may have been limited previously. According to Eurostat, Italy currently has a healthcare expenditure of $160 billion, while Spain has $120 billion. Therefore, high expenditure in the healthcare sector is driving the market’s growth.
Based on End-use, the market is segmented into Hospitals, Diagnostic Laboratories, Clinics, and Research Laboratories & Institutes. Based on Test Type, the market is segmented into TSH Test, Free T4 Test, T4 Test, T3 Test, Free T3 Test, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- Ulta Lab Tests, LLC
- DHA Laboratory
- Everly Health, Inc.
- ZRT Laboratory LLC
- Danaher Corporation
- Thyrocare Technologies Limited
- Siemens Healthineers AG (Siemens AG)
- Abbott Laboratories
Market Report Segmentation
By End-use- Hospitals
- Diagnostic Laboratories
- Clinics
- Research Laboratories & Institutes
- TSH Test
- Free T4 Test
- T4 Test
- T3 Test
- Free T3 Test
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Europe Thyroid Function Testing Market by End-use
Chapter 5. Europe Thyroid Function Testing Market by Test Type
Chapter 6. Europe Thyroid Function Testing Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- Ulta Lab Tests, LLC
- DHA Laboratory
- Everly Health, Inc.
- ZRT Laboratory LLC
- Danaher Corporation
- Thyrocare Technologies Limited
- Siemens Healthineers AG (Siemens AG)
- Abbott Laboratories
Methodology
LOADING...
